Philip Morris International (PMI) has recently come under fire for allegedly manipulating science in order to profit from their heated tobacco product, IQOS. Leaked documents have revealed that PMI and its Japanese affiliate have been funding research and advocacy work with scientists to attract non-smokers to their product. Japan, where IQOS was launched, has been a key market for PMI’s marketing strategy.
Researchers at the University of Bath’s Tobacco Control Research Group published a paper based on 24 leaked company documents dating from 2012 to 2020. The paper highlights PMI’s efforts to influence the conduct, publication, and reach of science to promote their products while concealing their activities. Dr. Sophie Braznell, one of the authors, emphasized that manipulating science for profit can have serious consequences, especially for policymakers and consumers making decisions about their health.
One concerning revelation from the leaked documents is PMI’s lobbying efforts to allow IQOS in places where smoking is banned. The company targeted various groups, including medical and hospitality organizations, as well as Japan’s Fire and Disaster Management Agency, to endorse IQOS. Additionally, PMI aimed to have a presence at the 2020 Tokyo Olympics, a move criticized for associating harmful products with health and potentially reaching children and young people.
Jorge Alday, director at Stop, a tobacco industry watchdog, pointed out that PMI’s actions contradict their claims that IQOS is only meant for adult smokers. The findings suggest a pattern of deceptive tactics that could contribute to a new chapter in the tobacco epidemic. Despite these allegations, a PMI spokesperson defended the company’s engagement with stakeholders, stating that it is essential for inclusive policymaking.
The leaked documents raise concerns about the transparency and integrity of PMI’s scientific research and marketing practices. Critics argue that corporate interests should not influence public health policies and call for reforms to safeguard science from vested interests. It is essential for regulators and policymakers to scrutinize the tobacco industry’s activities to protect consumers and public health from deceptive practices.
As the debate over the regulation of tobacco products continues, it is crucial for stakeholders to prioritize public health over profit motives. The revelations about PMI’s alleged manipulation of science underscore the need for greater transparency and accountability in the tobacco industry. Consumers must be empowered with accurate information to make informed decisions about their health and well-being.
